When leukemia returns after chemotherapy, multiple evidence-based treatments remain available, including CAR-T cell therapy, stem cell transplant, targeted immunotherapy, and clinical trials. Treatment selection depends on relapse timing, patient fitness, leukemia subtype, and whether the disease returned within or after 12 months of achieving remission. Key Takeaways Multiple treatment options exist for relapsed leukemia, with cure still possible depending on timing and pati

TL;DR Relapsed leukemia affects 15-20% of acute lymphoblastic leukemia (ALL) patients despite initial treatment success [1] , but multiple advanced treatment options now exist Pi Cancer Care provides comprehensive relapsed leukemia treatment protocols including CAR-T cell therapy, targeted immunotherapy, and stem cell transplantation with 80-85% complete remission rates for eligible patients Treatment selection depends on relapse timing (early vs. late), site of recurrence, a